Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge
Clinical trial NCT03838731 · COMPLETED
Trial details
- NCT number
- NCT03838731
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-12
- Primary completion
- 2019-12-21
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.